| Not Yet Recruiting | Predictive Score in Patients With Hematological Malignancies Colonized by Multidrug-resistant Enterobacteriace NCT07396571 | Fundación Pública Andaluza para la gestión de la Investigación en Sevilla | — |
| Not Yet Recruiting | Prospective Study Evaluate the Timing of Empirical Treatment for Carbapenem-resistant Bacterials (CROEAT Study NCT07047352 | Shanghai Jiao Tong University School of Medicine | N/A |
| Not Yet Recruiting | A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnos NCT07018271 | The First Affiliated Hospital of Soochow University | N/A |
| Recruiting | Real-world Study on the Prevention of Neutropenia After Tumor Treatment With Mecapegfilgrastim Injection NCT07434063 | Hebei Medical University Fourth Hospital | — |
| Recruiting | Luspatercept for Clonal Cytopenias of Uncertain Significance NCT06788691 | Weill Medical College of Cornell University | Phase 2 |
| Recruiting | Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers NCT07300735 | Alexandria University | N/A |
| Recruiting | UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia NCT06245746 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 1 |
| Not Yet Recruiting | Effects of Levetiracetam Monotherapy on Various Hematological Parameters in Adult Patients Suffering of Epilep NCT06491303 | Assiut University | — |
| Recruiting | Serial Blood Count Study NCT07066085 | University of Washington | EARLY_Phase 1 |
| Recruiting | Breath Analysis for the Detection of Invasive Fungal Infections NCT06537726 | University of Zurich | — |
| Recruiting | A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic NCT06056297 | X4 Pharmaceuticals | Phase 3 |
| Not Yet Recruiting | A Comparator Study of a Tasso Device Blood Sample to Traditional Venous Blood Sample for CBC NCT06360952 | Tasso Inc. | — |
| Recruiting | Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia NCT05537896 | West Virginia University | Phase 2 |
| Recruiting | The Prevalence and Impacts of Nudix Hydrolase 15 (NUDT15) Gene Variants in Taiwanese Inflammatory Bowel Diseas NCT06913998 | National Taiwan University Hospital | — |
| Active Not Recruiting | Continuous Versus Bolus Administration of G-CSF in Children With Cancer NCT06145321 | Chang Gung Memorial Hospital | Phase 4 |
| Recruiting | Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patie NCT06422533 | Instituto Nacional de Cancerologia de Mexico | N/A |
| Completed | Neutropenia With TNF-α Inhibitors NCT07237906 | Burak Ugur Cetin | — |
| Unknown | Investigation of the Usability of Neutrocheck Amongst Healthy Volunteers and Healthcare Professionals. NCT05852249 | 52 North Health Ltd | — |
| Unknown | Hematological Effects of Atypical Antipsychotics (AAPs) in a Geriatric Population: What is the Role of 5-HT2 R NCT06107322 | University Hospital, Strasbourg, France | — |
| Recruiting | Letermovir for Secondary Prophylaxis in Solid Organ Transplant Recipients NCT05626530 | Tufts Medical Center | Phase 4 |
| Unknown | Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignanci NCT05672420 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 1 / Phase 2 |
| Completed | Biosimilarity Study of Subcutaneous Pegfilgrastim in Healthy Volunteers NCT04873765 | Megalabs | Phase 1 |
| Completed | Letermovir Use in Heart Transplant Recipients NCT04904614 | Tufts Medical Center | Phase 4 |
| Completed | A Study of Mavorixafor in Participants With Congenital Neutropenia and Chronic Idiopathic Neutropenia Disorder NCT04154488 | X4 Pharmaceuticals | Phase 1 / Phase 2 |
| Completed | Screening for Colonization With Resistant Enterobacterales in Neutropenic Patients With Hematologic Malignanci NCT04710212 | Duke University | — |
| Completed | PC001- A Study to Evaluate the Usability of PointCheck NCT04448301 | Leuko Labs, Inc. | N/A |
| Completed | Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients NCT05221593 | Al-Azhar University | Phase 3 |
| Completed | Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in NCT04187898 | Spectrum Pharmaceuticals, Inc | Phase 1 |
| Completed | Late Neutropenia in VLBW Preterm Babies NCT04217811 | Hillel Yaffe Medical Center | — |
| Completed | AMS Intervention for Early Adaptation of Empirical Antibiotic Therapy in High-risk Neutropenic Patients NCT05793073 | Centre Hospitalier Universitaire de Nice | — |
| Completed | Safety of Acupuncture and Intracutaneous Needles in Pediatric Cancer Patients: a Retrospective Study (ACUSAFE2 NCT05585463 | Fundació Sant Joan de Déu | — |
| Completed | Efficacy and Safety of 4.5mg PEG-rhG-CSF Per Cycle in Preventing Neutropenia After Intensive Chemotherapy for NCT04009941 | Peking University | Phase 4 |
| Unknown | A Real World Study Evaluating the Clinical Application of PEG-rhG-CSF During Chemotherapy in Patients With Sol NCT03798665 | Affiliated Hospital of North Sichuan Medical College | — |
| Completed | Use of NGS Cell-free Pathogen Test for Identification of Low Risk Fever & Neutropenia in Pediatric Patients NCT03530072 | Karius, Inc. | — |
| Completed | Study to Compare the Efficacy and Safety of F-627 and GRAN® NCT04174599 | EVIVE Biotechnology | Phase 3 |
| Completed | Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy NCT03252431 | EVIVE Biotechnology | Phase 3 |
| Unknown | Efficacy of Granulocyte-Colony Stimulating Factor (G-CSF) NCT03498248 | DERSHENG SUN | N/A |
| Completed | Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer NCT05283616 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 3 |
| Completed | SPI-2012 vs Pegfilgrastim in Management of Neutropenia in Breast Cancer Participants With Docetaxel and Cyclop NCT02953340 | Spectrum Pharmaceuticals, Inc | Phase 3 |
| Completed | Isavuconazole in Preventing Invasive Fungal Infections in Adult Patients With Newly Diagnosed Acute Myeloid Le NCT03019939 | M.D. Anderson Cancer Center | Phase 2 |
| Unknown | Profiling Neutrophil Counts in Patients on Chemotherapy NCT02806557 | University of Leeds | — |
| Completed | Placebo-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy NCT02872103 | EVIVE Biotechnology | Phase 3 |
| Completed | Determining the Etiology of Febrile Neutropenia Using the Karius Sequencing-based Infectious Disease Diagnosti NCT02912117 | Karius, Inc. | — |
| Completed | Bioavailability Study of Lozanoc™ 65 mg Itraconazole Capsules in Patients Requiring Prophylaxis NCT02755857 | Mayne Pharma International Pty Ltd | Phase 2 |
| Completed | SPOG 2015 FN Definition. A Multi-center Non-inferiority Trial on Safety of a High Versus Low Temperature Limit NCT02324231 | Swiss Pediatric Oncology Group | N/A |
| Unknown | Blood Draw Validation for Ciprofloxacin Pharmacokinetic Research in Pediatric Cancer Patients NCT02967341 | Universitair Ziekenhuis Brussel | Phase 4 |
| Terminated | Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophospham NCT02685111 | Asan Medical Center | Phase 2 |
| Completed | SPI-2012 vs Pegfilgrastim in the Management of Neutropenia in Participants With Breast Cancer With Docetaxel a NCT02643420 | Spectrum Pharmaceuticals, Inc | Phase 3 |
| Completed | Pharmacokinetics and Pharmacodynamics Comparison Study Between Two Pegfilgrastim Formulations NCT02589301 | Eurofarma Laboratorios S.A. | Phase 1 |
| Completed | Steady-State Comparative Bioavailability Study in Prophylaxis Patients of Lozanoc® 50 mg With Sporanox® 100 mg NCT02621905 | Mayne Pharma International Pty Ltd | Phase 4 |
| Completed | Safety and Pharmacokinetics of Intravenous and Oral Posaconazole in Immunocompromised Children (MK-5592-097) NCT02452034 | Merck Sharp & Dohme LLC | Phase 1 |
| Completed | A Comparative Study to Evaluate the Effect of HSP-130, US-approved Neulasta and EU-approved Neulasta in Health NCT02629289 | Pfizer | Phase 1 |
| Completed | Vitamin Supplementation in NSCLC Patients on Pemetrexed Based Chemotherapy NCT02679443 | Post Graduate Institute of Medical Education and Research, Chandigarh | N/A |
| Completed | Home Away From Home - Medical Outcomes NCT02774850 | Children's Hospital of Philadelphia | — |
| Completed | A Study to Evaluate 5 μg/kg Tbo-filgrastim in Infants, Children and Adolescents With Solid Tumors Without Bone NCT02190721 | Teva Branded Pharmaceutical Products R&D, Inc. | Phase 2 |
| Completed | Mouthwash With Chlorhexidine 0.12%/Ethyl Alcohol 7% Compared to Ethyl Alcohol 7% NCT02414581 | Hospital Regional de Alta Especialidad del Bajio | Phase 3 |
| Completed | Safety and Efficacy of Human Myeloid Progenitor Cells (CLT-008) During Chemotherapy for Acute Myeloid Leukemia NCT02282215 | Cellerant Therapeutics | Phase 2 |
| Completed | Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome NCT02231879 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 2 / Phase 3 |
| Unknown | Pegfilgrastim on Day +3 Compared to Day +1 After Salvage Chemotherapy for Patients With Refractory or Relapsed NCT02238873 | Rabin Medical Center | Phase 3 |
| Completed | A Phase II, Dose-finding Study of F-627 in Patients With Breast Cancer Receiving Myelotoxic Chemotherapy. NCT02521441 | EVIVE Biotechnology | Phase 2 |
| Completed | A Pharmacokinetics/Dynamics Ib Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy NCT02522234 | EVIVE Biotechnology | Phase 1 / Phase 2 |
| Completed | Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis NCT01916057 | Assistance Publique - Hôpitaux de Paris | N/A |
| Completed | LIFEMEL Efficacy in Preventing Haematopoietic Toxicity in Patients Treated With Chemotherapy NCT04562922 | VitalMel | Phase 2 |
| Unknown | A Trial of MB-6 for Reduction of Neutropenia Induced by Chemotherapy in Patients With Stage III Colorectal Can NCT02135887 | Microbio Co Ltd | — |
| Unknown | Saftey and Efficacy of Pegfilgrastim in Preventing Chrmotherapy-induced Neutropenia NCT01918241 | Hangzhou Jiuyuan Gene Engineering Co. Ltd., | Phase 2 |
| Completed | Phase 2 Study of SPI-2012 or Pegfilgrastim for the Management of Neutropenia in Participants With Breast Cance NCT01724866 | Spectrum Pharmaceuticals, Inc | Phase 2 |
| Completed | Effect of Body Mass on Filgrastim Pharmacokinetics NCT01719432 | Aaron Cumpston, PharmD, BCOP | — |
| Completed | Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy NCT02527746 | EVIVE Biotechnology | Phase 1 |
| Completed | Piperacillin/Tazobactam for Empirical Therapy of Febrile Neutropenia NCT01714570 | Chinese PLA General Hospital | N/A |
| Unknown | Prophylactic Piperacillin/Tazobactam in Hematopoietic Stem Cell Transplantation NCT01714557 | Chinese PLA General Hospital | N/A |
| Withdrawn | Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant NCT01660347 | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | N/A |
| Completed | Clofarabine Followed By Lenalidomide for High-Risk Myelodysplastic Syndromes and Acute Myeloid Leukemia NCT01629082 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 1 |
| Completed | Dose-Finding Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy NCT01648322 | EVIVE Biotechnology | Phase 2 |
| Unknown | Prevention of Neutropenia After Using G-CSF With TAC Chemotherapy NCT01571518 | Hyuk moon Kim | Phase 4 |
| Unknown | A Study of Pegylated rhG-CSF as Support to Advanced Non-Small-Cell Lung Cancer (NSCLC) Patients Receiving Chem NCT01560195 | Jiangsu HengRui Medicine Co., Ltd. | Phase 3 |
| Completed | A Study Comparing Pegylated rhG-CSF and rhG-CSF as Support to Breast Cancer Patients Receiving Chemotherapy NCT01611051 | Jiangsu HengRui Medicine Co., Ltd. | Phase 3 |
| Unknown | Pharmacokinetics and Pharmacodynamics Study of Pegfilgrastim in Chemotherapy Patients NCT01637493 | Hangzhou Jiuyuan Gene Engineering Co. Ltd., | Phase 1 |
| Completed | Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care NCT01431326 | Daniel Benjamin | — |
| Completed | Levofloxacin in Preventing Infection in Young Patients With Acute Leukemia Receiving Chemotherapy or Undergoin NCT01371656 | Children's Oncology Group | Phase 3 |
| Unknown | Micafungin Prevention Study for Invasive Fungal Disease in Pediatric & Adolescent Patients Undergoing Autologo NCT01417169 | Seoul National University Hospital | Phase 2 |
| Completed | Decitabine for High-Risk Sickle Cell Disease NCT01375608 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Completed | A Study of Empirical Antifungal Therapy With Itraconazole NCT01706562 | Janssen Korea, Ltd., Korea | — |
| Completed | Study to Improve Survival Among HIV-Exposed Infants in Botswana NCT01229761 | Harvard School of Public Health (HSPH) | Phase 2 |
| Completed | Caspofungin Versus Fluconazole in Preventing Invasive Fungal Infections (IFI) in Patients Undergoing Chemother NCT01307579 | Children's Oncology Group | Phase 3 |
| Completed | A Phase II Study Comparing Pegylated rhG-CSF（HHPG-19K） and rhG-CSF in Breast Cancer Patients Receiving Chemoth NCT02119715 | Jiangsu HengRui Medicine Co., Ltd. | Phase 2 |
| Completed | Prolonged or Standard Infusion of Cefepime Hydrochloride in Treating Patients With Febrile Neutropenia NCT01484015 | Wake Forest University Health Sciences | Phase 1 |
| Completed | AMD 3100 for Treatment of Myelokathexis NCT01058993 | University of Washington | Phase 1 |
| Completed | Cyclophosphamide Plus Cyclosporine in Treatment-Naive Severe Aplastic Anemia NCT01193283 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 1 / Phase 2 |
| Completed | A Pilot Study of Fludarabine Plus Cyclophosphamide in Refractory Severe Aplastic Anemia NCT01187017 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 1 / Phase 2 |
| Unknown | Prevention of Febrile Neutropenia by Synbiotics in Pediatric Cancer Patients NCT02544685 | S&D Pharma SK s.r.o. | Phase 2 |
| Completed | Value of the LightCycler® SeptiFast Test MGRADE for the Pathogen Detection in Neutropenic Hematological Patien NCT01114165 | University Hospital Muenster | Phase 4 |
| Unknown | Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplant NCT01135589 | Asan Medical Center | Phase 4 |
| Completed | Biomarker-Guided Fluorouracil in Treating Patients With Colorectal Cancer Receiving Combination Chemotherapy NCT01164215 | UNC Lineberger Comprehensive Cancer Center | Phase 1 |
| Recruiting | A Phase I Study of Mozobil in the Treatment of Patients With WHIMS NCT00967785 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 1 / Phase 2 |
| Completed | PAVES: Pegfilgrastim Anti-vascular Endothelial Growth Factor (VEGF) Evaluation Study NCT00911170 | Amgen | Phase 3 |
| Terminated | An Evaluation Of The Effectiveness And Safety Of Anidulafungin Compared To Caspofungin For The Treatment Of Se NCT00806351 | Pfizer | Phase 3 |
| Completed | The Relationship of Defeverscence and Itraconazole Plasma Level Study in Immunocompromised Participants NCT01021683 | Janssen Korea, Ltd., Korea | — |
| Terminated | Outpatient Neutropenic Diet Study NCT00947648 | M.D. Anderson Cancer Center | Phase 2 |
| Terminated | Maintaining a Higher Level of Haemoglobin: Effect on the White Cells After Bone Marrow Transplantation in Chil NCT00937053 | St. Justine's Hospital | Phase 2 |
| Completed | Safety of Cotrimoxazole in HIV- and HAART-exposed Infants NCT01086878 | Harvard School of Public Health (HSPH) | Phase 4 |
| Completed | Diagnostic and Management Strategies for Invasive Aspergillosis NCT00816088 | King's College Hospital NHS Trust | — |
| Completed | Study of Drug to Reduce Thrombocytopenia in Patients Receiving Chemo for Ovarian, Fallopian Tube or Peritoneal NCT00771810 | Tarix Pharmaceuticals | Phase 2 |
| Completed | Unrelated Hematopoietic Stem Cell Transplantation(HSCT) for Genetic Diseases of Blood Cells NCT00730314 | Children's Hospital Los Angeles | Phase 1 / Phase 2 |
| Completed | Observational Study Investigating the Response Rate of Itraconazole Injection in Treating Immunocompromised Pa NCT01060462 | Janssen Korea, Ltd., Korea | — |
| Unknown | Therapeutic Drug Monitoring (TDM) of Voriconazole and Correlation With CYP2C19 Genotype in Korean Populations NCT00673348 | The Catholic University of Korea | — |
| Completed | Safety and Effectiveness of Granulocyte Transfusions in Resolving Infection in People With Neutropenia (The RI NCT00627393 | Carelon Research | Phase 3 |
| Completed | Assessment of New Blood Culture Methods on the Microbiological Documentation of Febrile Neutropenia NCT00913042 | Assistance Publique - Hôpitaux de Paris | — |
| Completed | A Pharmacokinetic Study of JK1211(Itraconazole [Itrizole]) Oral Solution in Participants With Deep Mycosis and NCT00784368 | Janssen Pharmaceutical K.K. | Phase 3 |
| Completed | Oral Posaconazole in High Risk Patients With Gastrointestinal Dysfunction (Study P05115) NCT00686543 | Merck Sharp & Dohme LLC | Phase 4 |
| Unknown | A Pilot Study to Evaluate the Safety and Activities of EW02 in Reducing Neutropenia Caused by Chemotherapy NCT00555516 | Tri-Service General Hospital | Phase 1 / Phase 2 |
| Completed | The Utility of Multiplex PCR for Detection of DNA in Neutropenic Patients With Hematological Malignancies NCT01669005 | Centre Hospitalier Universitaire Vaudois | — |
| Terminated | A Study of Ceftobiprole in Patients With Fever and Neutropenia. NCT00529282 | Basilea Pharmaceutica | Phase 3 |
| Completed | G-CSF in Preventing Neutropenia in Women Receiving Chemotherapy for Breast Cancer NCT00771433 | Centre Francois Baclesse | Phase 2 |
| Completed | G-CSF in Preventing Neutropenia in Patients With Solid Tumors Who Are Receiving Chemotherapy NCT00770172 | Centre Francois Baclesse | Phase 3 |
| Completed | Safety and Efficacy Study of GCSF Therapy to Treat Patients at High Risk for Chemotherapy Induced Severe Neutr NCT00497809 | AviGenics | Phase 2 |
| Unknown | Early Hospital Discharge or Standard Inpatient Care in Cancer Patients Receiving Antibiotics for Febrile Neutr NCT00445497 | Clatterbridge Centre for Oncology | Phase 3 |
| Withdrawn | A Study of Safety, Tolerability, and Pk of rhMBL in Pediatric Hematology/Oncology Pts With Fever and Neutropen NCT00520325 | Enzon Pharmaceuticals, Inc. | Phase 1 |
| Completed | Daptomycin in Treating Neutropenia and Fever in Patients With Cancer NCT00335478 | OHSU Knight Cancer Institute | Phase 2 |
| Withdrawn | Recombinant Human Mannose-Binding Lectin (MBL) in Treating Young Patients With MBL Deficiency and Fever and Ne NCT00886496 | Enzon Pharmaceuticals, Inc. | Phase 1 |
| Unknown | Garlic in Patients With Febrile Neutropenia NCT00247039 | Hadassah Medical Organization | Phase 1 / Phase 2 |
| Completed | Carboplatin, Paclitaxel, and Pegfilgrastim in Treating Patients With Stage III or Stage IV Ovarian Epithelial, NCT00352300 | Gynecologic Oncology Group | Phase 1 |
| Completed | Dose Finding Study of KRN125 (Pegfilgrastim) for Treatment of Neutropenic Patients NCT00364468 | Kyowa Kirin Co., Ltd. | Phase 2 |
| Withdrawn | Fever and Neutropenia in Pediatric Oncology Patients NCT03768869 | University of Colorado, Denver | Phase 3 |
| Completed | Three Immunosuppressive Treatment Regimens for Severe Aplastic Anemia NCT00260689 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Withdrawn | Daptomycin or Vancomycin in Treating Bacteria in the Blood in Patients With Neutropenia Caused By Chemotherapy NCT00296049 | Wake Forest University Health Sciences | N/A |
| Completed | Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cel NCT00077311 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Completed | FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherap NCT00125723 | Amgen | Phase 4 |
| Completed | Study on Mannan Binding Lectin (MBL) Substitution in MBL-Deficient Children With Chemotherapy-Induced Neutrope NCT00138736 | Prothya Biosolutions | Phase 2 |
| Completed | MK0991 Versus Amphotericin B for Empirical Therapy in Febrile, Neutropenic Pediatric Patients (0991-044) NCT00082537 | Merck Sharp & Dohme LLC | Phase 2 |
| Completed | Granulocyte Transfusions in Hematological Patients With Febrile Neutropenia NCT02544230 | Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne | — |
| Terminated | Low-risk Fever and Neutropenia in Children With Cancer: Safety and Efficacy of Oral Antibiotics in an Outpatie NCT00107081 | Swiss Pediatric Oncology Group | Phase 3 |
| Completed | Safety, Tolerance and Pharmacokinetics of Anidulafungin in Immunocompromised Children Ages 2-17 NCT00056381 | Pfizer | Phase 1 / Phase 2 |
| Completed | Anidulafungin in Treating Immunocompromised Children With Neutropenia NCT00068471 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Natural History Study for BEN NCT00059423 | National Heart, Lung, and Blood Institute (NHLBI) | — |
| Completed | Voriconazole in Preventing Fungal Infections in Children With Neutropenia After Chemotherapy NCT00066599 | National Cancer Institute (NCI) | Phase 2 |
| Completed | A Study to Investigate the Pharmacokinetics, Safety and Tolerability of Voriconazole in Children NCT00174473 | Pfizer | Phase 1 / Phase 2 |
| Completed | Prophylaxis Trial of Posaconazole Versus Standard Azole Therapy for Neutropenic Patients (Study P01899) NCT00044486 | Merck Sharp & Dohme LLC | Phase 3 |
| Completed | A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy i NCT00277160 | Amgen | Phase 4 |
| Terminated | Moxifloxacin Compared With Ciprofloxacin/Amoxicillin in Treating Fever and Neutropenia in Patients With Cancer NCT00062231 | European Organisation for Research and Treatment of Cancer - EORTC | N/A |
| Completed | Once-Daily Amikacin Plus Cloxacillin in Febrile Neutropenic Children NCT00129688 | Khon Kaen University | N/A |
| Completed | Genetic Trial to Study Diarrhea in Patients With Stage III Colon Cancer Who Are Receiving Chemotherapy NCT00048971 | Alliance for Clinical Trials in Oncology | — |
| Completed | Cyclosporine in Treating Patients With Low Blood Counts Caused By Hematologic Cancer NCT00031980 | Alliance for Clinical Trials in Oncology | Phase 2 |
| Completed | Pegfilgrastim as Support to Advanced Breast Cancer Patients Receiving Chemotherapy NCT00035594 | Amgen | Phase 3 |
| Terminated | Treatment of Anemia and Neutropenia in HIV/HCV Coinfected Patients Treated With Pegylated Interferon and Ribav NCT00194857 | Weill Medical College of Cornell University | Phase 4 |
| Unknown | Filgrastim or Pegfilgrastim in Preventing Neutropenia in Women Receiving Chemotherapy Following Surgery for Br NCT00030758 | Anglo Celtic Cooperative Oncology Group | Phase 4 |
| Unknown | Levofloxacin Compared With Cefepime in Treating Cancer Patients With Fever and Neutropenia NCT00020865 | Jonsson Comprehensive Cancer Center | Phase 3 |
| Completed | The Tobramycin Study NCT00257790 | Oslo University Hospital | Phase 4 |
| Completed | Using Whole-Person-Care Guide in Patients Receiving Care for Cancer or Complications From Cancer Treatment NCT00608738 | Northwestern University | N/A |
| Completed | Caspofungin Acetate in Treating Children With Fever and Neutropenia NCT00020527 | National Cancer Institute (NCI) | N/A |
| Withdrawn | Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML NCT00003407 | Rush University Medical Center | Phase 2 |
| Completed | BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy NCT00020371 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant He NCT00005893 | Fairview University Medical Center | N/A |
| Completed | Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma NCT00004192 | University of Nebraska | Phase 2 |
| Completed | Pegfilgrastim as Support to Pediatric Sarcoma Patients Receiving Chemotherapy NCT00035620 | Amgen | Phase 2 |
| Terminated | Peripheral Stem Cell Transplantation to Prevent Neutropenia in Patients Receiving Chemotherapy for Relapsed or NCT00005787 | Northwestern University | Phase 1 |
| Completed | Leridistim Compared With Filgrastim in Treating Older Patients With Acute Myeloid Leukemia NCT00004215 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Antibiotic Therapy With or Without G-CSF in Treating Children With Neutropenia and Fever Caused by Chemotherap NCT00003739 | Children's Oncology Group | Phase 3 |
| Completed | Phase I Study of the Safety, Tolerance, and Pharmacokinetics of FK463 in Immunocompromised Children With Fever NCT00001790 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis NCT00001646 | National Institute of Allergy and Infectious Diseases (NIAID) | Phase 3 |
| Completed | Treatment of T-Large Granular Lymphocyte (T-LGL) Lymphoproliferative Disorders With Cyclosporine NCT00001533 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 1 |
| Completed | Docetaxel and Epirubicin With and Without G-CSF in Treating Women With Metastatic Breast Cancer NCT00002866 | NCIC Clinical Trials Group | Phase 1 |
| Completed | Chemotherapy in Treating Patients With Newly Diagnosed Acute or Chronic Myelogenous Leukemia or Myelodysplasti NCT00002800 | Memorial Sloan Kettering Cancer Center | Phase 2 |
| Completed | Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or Lymphoma NCT00002759 | National Cancer Institute (NCI) | Phase 1 |
| Completed | Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia NCT00002719 | European Organisation for Research and Treatment of Cancer - EORTC | Phase 3 |
| Completed | Combination Chemotherapy in Treating Patients With Chronic Myelogenous Leukemia or Recurrent Acute Leukemia NCT00002693 | Mayo Clinic | Phase 1 |
| Completed | SWOG-9400 Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Patients With Previ NCT00002665 | SWOG Cancer Research Network | Phase 2 |
| Completed | Combination Chemotherapy in Treating Patients With Newly Diagnosed Metastatic Ewing's Sarcoma or Primitive Neu NCT00002643 | National Cancer Institute (NCI) | Phase 2 |
| Recruiting | Cologne Cohort of Neutropenic Patients (CoCoNut) NCT01821456 | University Hospital of Cologne | — |
| Unknown | International Registry for Severe Chronic Neutropenia NCT00004342 | National Center for Research Resources (NCRR) | — |
| Unknown | Combination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute NCT00002658 | Medical Research Council | Phase 3 |
| Completed | A Prospective, Randomized, Phase III Trial of FLAC (5-Fluorouracil, Leucovorin, Adriamycin, Cytoxan) Chemother NCT00001338 | National Cancer Institute (NCI) | Phase 3 |
| Completed | Same Day Dosing of Pegfilgrastim in Breast Cancer Patients Undergoing Chemotherapy (TAC) NCT00115414 | Amgen | Phase 2 |
| Completed | A Randomized, Open Label, Comparative, Multicenter Trial of Voriconazole Vs. AmBisome for Empirical Antifungal NCT00008840 | National Institute of Allergy and Infectious Diseases (NIAID) | — |